CN100525832C - 伴侣蛋白10的免疫抑制作用 - Google Patents

伴侣蛋白10的免疫抑制作用 Download PDF

Info

Publication number
CN100525832C
CN100525832C CNB2003801082969A CN200380108296A CN100525832C CN 100525832 C CN100525832 C CN 100525832C CN B2003801082969 A CNB2003801082969 A CN B2003801082969A CN 200380108296 A CN200380108296 A CN 200380108296A CN 100525832 C CN100525832 C CN 100525832C
Authority
CN
China
Prior art keywords
cpn10
cells
gvhd
donor
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2003801082969A
Other languages
English (en)
Chinese (zh)
Other versions
CN1735428A (zh
Inventor
G·R·希尔
T·巴诺维奇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CBio Ltd
Original Assignee
CBio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CBio Ltd filed Critical CBio Ltd
Publication of CN1735428A publication Critical patent/CN1735428A/zh
Application granted granted Critical
Publication of CN100525832C publication Critical patent/CN100525832C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CNB2003801082969A 2002-11-06 2003-11-06 伴侣蛋白10的免疫抑制作用 Expired - Fee Related CN100525832C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2002952492A AU2002952492A0 (en) 2002-11-06 2002-11-06 Chaperonin 10 immunosuppression
AU2002952492 2002-11-06

Publications (2)

Publication Number Publication Date
CN1735428A CN1735428A (zh) 2006-02-15
CN100525832C true CN100525832C (zh) 2009-08-12

Family

ID=28795882

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2003801082969A Expired - Fee Related CN100525832C (zh) 2002-11-06 2003-11-06 伴侣蛋白10的免疫抑制作用

Country Status (16)

Country Link
US (3) US7618935B2 (https=)
EP (3) EP2255824B1 (https=)
JP (2) JP4716731B2 (https=)
KR (1) KR101088740B1 (https=)
CN (1) CN100525832C (https=)
AT (1) ATE489963T1 (https=)
AU (1) AU2002952492A0 (https=)
CA (1) CA2505141C (https=)
CY (1) CY1110972T1 (https=)
DE (1) DE60335202D1 (https=)
DK (1) DK1569679T3 (https=)
ES (1) ES2351993T3 (https=)
NZ (1) NZ540433A (https=)
PT (1) PT1569679E (https=)
SI (1) SI1569679T1 (https=)
WO (1) WO2004041300A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005204979B2 (en) * 2004-01-16 2010-10-21 Cbio Limited Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
US20070275890A1 (en) * 2004-01-16 2007-11-29 Johnson Barbara J Chaperonin 10 Modulation Of Toll-Like Receptor-Inducible Cytokine And Chemokine Secretion
US8036710B2 (en) * 2004-05-07 2011-10-11 Qualcomm, Incorporated Power-efficient multi-antenna wireless device
JP2009500430A (ja) * 2005-07-11 2009-01-08 シーバイオ リミテッド シャペロニン１０により誘導される免疫調整方法
AU2006269824B2 (en) * 2005-07-11 2012-04-19 Cbio Limited Chaperonin 10-induced immunomodulation
CN101309934B (zh) 2005-08-31 2014-02-12 悉生物有限公司 修饰的伴侣蛋白10
AU2006303826B2 (en) * 2005-10-20 2012-07-19 Cbio Limited Treatment of hypersensitivity
JP2009511610A (ja) * 2005-10-20 2009-03-19 シービーアイオー リミテッド 過敏症治療
MX2008011167A (es) 2006-03-02 2008-11-12 Cbio Ltd Regulaciòn de respuestas inmunes mediante la modulaciòn de la funciòn de cèlulas presentadoras de antìgenos.
CA2720617A1 (en) * 2008-04-11 2009-10-15 Cbio Limited Modified cpn10 and prr signalling
US20110243921A1 (en) * 2010-03-30 2011-10-06 Cbio Limited Prevention and treatment of cutaneous lupus erythematosus
WO2013158959A1 (en) * 2012-04-19 2013-10-24 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of graft-versus-host disease
WO2014063194A1 (en) 2012-10-23 2014-05-01 The University Of Sydney Elastic hydrogel
ES2860023T3 (es) 2012-12-10 2021-10-04 Allergan Pharmaceuticals Int Ltd Fabricación de constructos elásticos tridimensionales escalables
KR20230004965A (ko) 2013-08-13 2023-01-06 앨러간 파마슈티컬스 인터내셔널 리미티드 손상 조직의 재생

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002040038A2 (en) * 2000-11-17 2002-05-23 Helperby Therapeutics Limited M. tuberculosis chaperonin 10 and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2176948C (en) * 1993-11-30 2007-05-15 Halle Morton Chaperonin 10
PT731811E (pt) 1993-11-30 2005-04-29 Univ Queensland Chaperonina 10
US5989804A (en) * 1994-07-08 1999-11-23 New England Medical Center Hospitals, Inc. E6 binding proteins
CA2228379A1 (en) * 1995-08-09 1997-02-20 Schering Corporation Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
US20020142000A1 (en) * 1999-01-15 2002-10-03 Digan Mary Ellen Anti-CD3 immunotoxins and therapeutic uses therefor
CA2383213A1 (en) * 1999-09-10 2001-03-15 Fordham University Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002040038A2 (en) * 2000-11-17 2002-05-23 Helperby Therapeutics Limited M. tuberculosis chaperonin 10 and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Immunosuppression precoce et implantation. CHAOUAT G.CONTRACEPTION,FERTILITE,SEXUALITE,Vol.23 No.10. 1995 *
Increased expression of HDJ-2 (heat shock protein) and heatshock protein 70 in biopsy specimens of transplanted humanlungs. Rizzo Monica et al.The JOURNAL OF HEART AND LUNG TRANSPLANTATION,Vol.17 No.3. 1998 *

Also Published As

Publication number Publication date
AU2002952492A0 (en) 2002-11-21
US7618935B2 (en) 2009-11-17
EP1569679B1 (en) 2010-12-01
WO2004041300A1 (en) 2004-05-21
JP2011088920A (ja) 2011-05-06
EP2255824A1 (en) 2010-12-01
CA2505141C (en) 2012-07-17
KR101088740B1 (ko) 2011-12-01
JP4716731B2 (ja) 2011-07-06
EP1569679A4 (en) 2008-02-27
EP2818179A1 (en) 2014-12-31
EP1569679A1 (en) 2005-09-07
DK1569679T3 (da) 2011-01-10
CA2505141A1 (en) 2004-05-21
NZ540433A (en) 2008-03-28
EP2255824B1 (en) 2014-07-23
SI1569679T1 (sl) 2011-01-31
US20100099605A1 (en) 2010-04-22
CN1735428A (zh) 2006-02-15
US20060198834A1 (en) 2006-09-07
DE60335202D1 (en) 2011-01-13
PT1569679E (pt) 2010-12-14
CY1110972T1 (el) 2015-06-11
US20120082690A1 (en) 2012-04-05
KR20050086428A (ko) 2005-08-30
ATE489963T1 (de) 2010-12-15
JP2006508099A (ja) 2006-03-09
US8067361B2 (en) 2011-11-29
ES2351993T3 (es) 2011-02-14

Similar Documents

Publication Publication Date Title
US8067361B2 (en) Chaperonin 10 immunosuppression
Cruse et al. Illustrated dictionary of immunology
Robert et al. Phylogenetic conservation of the molecular and immunological properties of the chaperones gp96 and hsp70
JPH09509944A (ja) Ｔ細胞調節のための製品と方法
JPH09510444A (ja) 自己免疫疾患の治療におけるｉｌ−１２およびｉｌ−１２アンタゴニストの使用
IL194987A (en) Use of PIF peptide to produce a drug to regulate the immune system
AU2008202216A1 (en) Combination therapies for immune mediated diseases
KR20240023035A (ko) 자가면역 치료를 위한 hla 조작 방법 및 조성물
WO1992006117A1 (en) Inhibiting unwanted immune responses
Kleinau et al. A monoclonal antibody to the mycobacterial 65kDa heat shock protein (ML 30) binds to cells in normal and arthritic joints of rats
JP4452312B2 (ja) Ｔ細胞抗原受容体ペプチド
JPH10505839A (ja) グラム陽性細菌及びマイコバクテリアの作用を阻止するための抗体の使用
JPH09504432A (ja) Ｍｈｃタンパク質の原核発現
CA2418445A1 (en) Stress proteins and peptides and methods of use thereof
JPH07502165A (ja) Ｔリンパ球の限定された個体群に対する抗体を生産する方法、抗体および使用方法
AU2003277992B2 (en) Chaperonin 10 immunosuppression
US20040116344A1 (en) Immunomodulatory properties of bip
WO1999051633A1 (en) Proteins having immunomodulatory activity and remedies for immunological diseases
AU2002337708A1 (en) Combination therapies for immune mediated diseases
Vallejo Antigen processing and presentation in channel catfish immune responses
HK1003512A1 (en) Prevention and treatment of allergic diseases by recombinant plasmid encoded allergen
HK1003512B (en) Prevention and treatment of allergic diseases by recombinant plasmid encoded allergen

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090812

Termination date: 20161106